scispace - formally typeset
A

Astrid Schauss

Researcher at University of Cologne

Publications -  56
Citations -  3621

Astrid Schauss is an academic researcher from University of Cologne. The author has contributed to research in topics: Mitochondrion & Mitochondrial fission. The author has an hindex of 25, co-authored 50 publications receiving 2832 citations. Previous affiliations of Astrid Schauss include University of Ottawa & Max Planck Society.

Papers
More filters
Journal ArticleDOI

The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission

TL;DR: OPA1 processing by YEM1L and OMA1 is dispensable for mitochondrial fusion and instead drives mitochondrial fragmentation, which is crucial for mitochondrial integrity and quality control.
Journal ArticleDOI

Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers.

TL;DR: The data are the first to identify MAPL, describe and characterize MDVs, and define a new intracellular transport route between mitochondria and peroxisomes, marking the first evidence for a direct relationship between these two functionally related organelles.
Journal ArticleDOI

Extracellular vesicle measurements with nanoparticle tracking analysis – An accuracy and repeatability comparison between NanoSight NS300 and ZetaView

TL;DR: ZetaView provided a more accurate and repeatable depiction of EV concentration, whereas NanoSight NS300 supplied size measurements of higher resolution that failed to report a peak EV diameter below 60 nm compared to TEM and SP-IRIS.
Journal ArticleDOI

The SUMO protease SENP5 is required to maintain mitochondrial morphology and function

TL;DR: It is demonstrated that the cytosolic pool of SENP5 catalyzes the cleavage of SUMO1 from a number of mitochondrial substrates, impacting mitochondrial morphology and metabolism.
Journal ArticleDOI

A novel multiplex bead-based platform highlights the diversity of extracellular vesicles

TL;DR: A novel multiplex bead-based platform to investigate up to 39 different surface markers in one sample and show for the first time that NK cell–derived EVs and platelet-derived EVs are devoid of CD9 or CD81, respectively, and that EVs isolated from activated B cells comprise different EV subpopulations.